| product Name | (S)-1-Boc-3-hydroxypiperidine |
|---|---|
| CAS No | 143900-44-1 |
| Synonyms | (S)-1-N-Boc-3-Hydroxy-Piperidine; (S)-3-Hydroxy-Piperidine-1-Carboxylic Acid Tert-Butyl Ester; (S)-3-Hydroxy-1-(Tert-Butoxycarbonyl)Piperidine; (S)-1-Boc-3-Piperidinol; (S)-N-(Tert-Butoxycarbonyl)-3-Hydroxypiperidine Hydrochloride; (S)-N-Boc-3-Hydroxy Piperidine; (S)-Tert Butyl-3-Hydroxypiperidine-1-Carboxylate; tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate; (S)-N-BOC-3-piperidinol; (S)-N-Boc-3-piperidine |
| Molecular Formula | C10H19NO3 |
| Molecular Weight | 201.2628 |
| InChI | InChI=1/C10H19NO3/c1-10(2,3)14-9(13)11-6-4-5-8(12)7-11/h8,12H,4-7H2,1-3H3/t8-/m0/s1 |
| Molecular Structure | 
|
| Density | 1.107g/cm3 |
| Melting point | 34-40℃ |
| Boiling point | 292.3°C at 760 mmHg |
| Refractive index | 1.495 |
| Flash point | 130.6°C |
| Vapour Pressur | 0.000198mmHg at 25°C |
| Uses | 1.(S)-1-Boc-3-hydroxypiperidine is an important chiral intermediate for the synthesis of ibrutinib, an anticancer drug targeting B-cell malignancies. Synthesis of pharmaceutical intermediates including ibrutinib, the API of the newly approved drug Imbruvica, for the treatment of lymphoma.
2.A piperidine derivative with an amine protecting group, (S)-1-Boc-3-hydroxypiperidine can be used in the preparation of biologically active compounds such as antagonists of the human P2X7 receptor and selective irreversible inhibitors for bruton’s tyrosine kinase. 3.(S)-1-Boc-3-hydroxypiperidine is used as pharmaceutical intermediate. |
| Chemical Properties | White Powder |
| Description | (S)-1-Boc-3-hydroxypiperidine, alias (S)-N-Boc-3-hydroxypiperidine (S-NBHP) is an important chiral intermediate for the synthesis of ibrutinib, an anticancer drug targeting B-cell malignancies.S-NBHP can be prepared in a variety of ways such as chemically or biocatalytically. S-NBHP can be prepared in various ways, such as chemical synthesis or biocatalysis. Biocatalysis is an efficient process for the reduction of N-Boc-piperidin-3-one by recombinant keto reductase (KRED) catalytic to obtain optically pure S-NBHP using 99% yield. The asymmetric reduction of N-Boc-piperidin-3-one (NBPO) to (S)-NBHP can also be catalysed by a reductase (YDR541C) isolated from Saccharomyces cerevisiae in 99% yield. |
Reviews
There are no reviews yet.